Inhibition of GPR30 sensitized gefitinib to NSCLC cells via regulation of epithelial-mesenchymal transition
Conclusion: Taken together, these data suggested that G15 could enhance NSCLC sensitivity to gefitinib by inhibition of GPR30 and EMT.PMID:37890097 | PMC:PMC10612443 | DOI:10.1177/03946320231210737
Source: International Journal of Immunopathology and Pharmacology - Category: Allergy & Immunology Authors: Xiaomin Yang Hongyan Jiang Jiang Ning Shufen Zhang Ying Cai Liang Wang Jinsong Yang Guodong Xu Wei Chen Jianfei Wang Source Type: research
More News: Allergy & Immunology | Cancer | Cancer & Oncology | Drugs & Pharmacology | Epithelial Cancer | Lung Cancer | Non-Small Cell Lung Cancer | Study